InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: Ej23ny post# 10700

Thursday, 09/19/2019 5:09:19 PM

Thursday, September 19, 2019 5:09:19 PM

Post# of 18220
Be very, very careful in your public statements! Neither Immune Therapeutics, Inc., nor Cytocom, Inc., have initiated any FDA approved clinical studies in the Crohn's Disease area to prompt your statement: "The Company has reported very good results and the chance for approval is very high."